Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks?

By Ian Bezek, InvestorPlace Contributor

With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.

Investors Should Sell Adobe Stock

By Ian Bezek, InvestorPlace Contributor

Adobe stock has risen rapidly over the last month. As a result, it's a good time to take profits on ADBE stock ahead of what could be an underwhelming 2019.

Here’s What’s Next for Disney Stock After Disappointing Earnings

By Ian Bezek, InvestorPlace Contributor

When will Disney stock finally get moving again? Here's what you need to know about the company's streaming service rollout in 2019.

7 Bank Stocks to Buy After the BB&T-Suntrust Mega-Merger

By Ian Bezek, InvestorPlace Contributor

BB&T is buying Suntrust in a gargantuan $66 billion deal. Which banking stocks will benefit next as the M&A wave rolls in?

Zynerba Stock Is Marijuana-Adjacent Play Worth a Look

By Ian Bezek, InvestorPlace Contributor

Zynerba has a CBD gel that looks like a promising treatment for various neurological diseases. What does it mean for ZYNE stock?

Load More